Eliem Therapeutics (ELYM) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ELYM Stock Alerts $9.32 -0.88 (-8.63%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Eliem Therapeutics Short Interest DataCurrent Short Volume601,100 sharesPrevious Short Volume13,200 sharesChange Vs. Previous Month+4,453.79%Dollar Volume Sold Short$2.86 millionShort Interest Ratio / Days to Cover0.9Last Record DateApril 15, 2024Outstanding Shares27,724,000 sharesFloat Size18,440,000 sharesShort Percent of Float3.26%Today's Trading Volume304,666 sharesAverage Trading Volume624,483 sharesToday's Volume Vs. Average49% Short Selling Eliem Therapeutics ? Sign up to receive the latest short interest report for Eliem Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatELYM Short Interest Over TimeELYM Days to Cover Over TimeELYM Percentage of Float Shorted Over Time Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Eliem Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024601,100 shares $2.86 million +4,453.8%3.3%0.9 $4.75 3/31/202413,200 shares $36,168.00 +1.5%0.1%1.2 $2.74 3/15/202413,000 shares $35,100.00 +19.3%0.1%1.9 $2.70 2/29/202410,900 shares $29,757.00 +12.4%0.1%1.1 $2.73 2/15/20249,700 shares $25,705.00 +1.0%0.1%1 $2.65 1/31/20249,600 shares $24,576.00 +1.1%0.1%0.8 $2.56 Get the Latest News and Ratings for ELYM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20249,500 shares $25,840.00 -23.4%0.1%0.8 $2.72 12/31/202312,400 shares $33,480.00 -46.8%0.1%1 $2.70 12/15/202323,300 shares $63,609.00 -30.7%0.1%1.5 $2.73 11/30/202333,600 shares $86,016.00 -4.8%0.2%2.5 $2.56 11/15/202335,300 shares $88,250.00 -14.9%0.2%2.3 $2.50 10/31/202341,500 shares $109,145.00 +4.8%0.2%2.7 $2.63 10/15/202339,600 shares $103,356.00 -0.5%0.2%2.3 $2.61 9/30/202339,800 shares $104,674.00 +6.7%0.2%1.1 $2.63 9/15/202337,300 shares $101,083.00 -14.1%0.2%1.1 $2.71 8/31/202343,400 shares $115,010.00 -18.4%0.2%1.4 $2.65 8/15/202353,200 shares $142,044.00 -15.2%0.3%1.9 $2.67 7/31/202362,700 shares $168,036.00 +91.7%0.4%2.3 $2.68 7/15/202332,700 shares $92,541.00 +1.9%0.2%1.3 $2.83 6/30/202332,100 shares $89,880.00 +3.2%0.2%4.6 $2.80 6/15/202331,100 shares $87,702.00 -16.6%0.2%4.9 $2.82 5/31/202337,300 shares $108,916.00 +98.4%0.2%5 $2.92 5/15/202318,800 shares $56,024.00 -5.5%0.1%1.3 $2.98 4/30/202319,900 shares $62,486.00 +33.6%0.1%1.2 $3.14 4/15/202314,900 shares $46,935.00 -39.4%0.1%0.8 $3.15 3/31/202324,600 shares $71,340.00 +25.5%0.1%1.5 $2.90 3/15/202319,600 shares $59,584.00 -55.2%0.1%1 $3.04 2/28/202343,700 shares $155,572.00 +39.6%0.3%2.5 $3.56 2/15/202331,300 shares $79,815.00 +16.4%0.2%2.3 $2.55 1/31/202326,900 shares $94,150.00 +28.1%0.2%3.6 $3.50 1/15/202321,000 shares $85,365.00 +81.0%0.1%3 $4.07 12/30/202211,600 shares $42,572.00 -95.1%0.1%1.6 $3.67 12/15/2022238,500 shares $624,870.00 -0.2%1.3%31 $2.62 11/30/2022238,900 shares $611,584.00 -0.2%1.4%26.5 $2.56 11/15/2022239,300 shares $720,293.00 -0.1%1.4%15.4 $3.01 10/31/2022239,600 shares $783,492.00 -0.5%1.4%11 $3.27 10/15/2022240,800 shares $852,432.00 -0.7%1.4%8.6 $3.54 9/30/2022242,600 shares $783,598.00 -2.9%1.4%6.4 $3.23 9/15/2022249,900 shares $797,181.00 +1.7%1.4%5 $3.19 8/31/2022245,800 shares $752,148.00 -5.9%1.4%4.1 $3.06Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now ELYM Short Interest - Frequently Asked Questions What is Eliem Therapeutics' current short interest? Short interest is the volume of Eliem Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 601,100 shares of ELYM short. 3.26% of Eliem Therapeutics' shares are currently sold short. Learn More on Eliem Therapeutics' current short interest. What is a good short interest ratio for Eliem Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELYM shares currently have a short interest ratio of 1.0. Learn More on Eliem Therapeutics's short interest ratio. What is a good short interest percentage for Eliem Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.26% of Eliem Therapeutics' floating shares are currently sold short. Is Eliem Therapeutics' short interest increasing or decreasing? Eliem Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 601,100 shares, an increase of 4,453.8% from the previous total of 13,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Eliem Therapeutics' float size? Eliem Therapeutics currently has issued a total of 27,724,000 shares. Some of Eliem Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eliem Therapeutics currently has a public float of 18,440,000 shares. How does Eliem Therapeutics' short interest compare to its competitors? 3.26% of Eliem Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Eliem Therapeutics: RAPT Therapeutics, Inc. (9.14%), Inozyme Pharma, Inc. (7.66%), XOMA Co. (2.42%), XBiotech Inc. (3.40%), Xeris Biopharma Holdings, Inc. (6.03%), CytomX Therapeutics, Inc. (5.27%), Enanta Pharmaceuticals, Inc. (13.94%), Verastem, Inc. (3.94%), Nektar Therapeutics (1.75%), Akebia Therapeutics, Inc. (6.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Eliem Therapeutics stock? Short selling ELYM is an investing strategy that aims to generate trading profit from Eliem Therapeutics as its price is falling. ELYM shares are trading down $0.88 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eliem Therapeutics? A short squeeze for Eliem Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELYM, which in turn drives the price of the stock up even further. How often is Eliem Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELYM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: RAPT Short Squeeze INZY Short Squeeze XOMA Short Squeeze XBIT Short Squeeze XERS Short Squeeze CTMX Short Squeeze ENTA Short Squeeze VSTM Short Squeeze NKTR Short Squeeze AKBA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELYM) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing“Crash Insurance” For Your RetirementUnstoppable Prosperity